Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

Human skin models are essential for studying skin's sensory, immune, and nervous system interactions.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Certain fungi protect skin health, but changes can allow harmful fungi to cause serious infections, needing more research for treatment and control.

Restoring hair follicle immune privilege may help treat alopecia areata.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Alopecia areata doesn't significantly change the risk of common infections.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Genetic differences affect how people respond to COVID-19.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Mouse stem cells from hair follicles can improve wound healing and reduce scarring.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.